Cargando…
The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma
BACKGROUND: Mitofusin 2 (MFN2) plays an important role in many tumors, but how its role in renal clear cell carcinoma needs further research. METHODS: In this study, we analyzed the expression of MFN2 in renal clear cell carcinoma tissues and normal kidney tissues through the Cancer Genome Atlas (TC...
Autores principales: | Zhang, Bin, Han, Dali, Yang, LiMing, He, Yang, Yang, Shujun, Wang, Hongbo, Zhang, Xingxing, Du, Yuelin, Xiong, Wei, Ha, Hualan, Shang, Panfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577979/ https://www.ncbi.nlm.nih.gov/pubmed/37845657 http://dx.doi.org/10.1186/s12885-023-11419-8 |
Ejemplares similares
-
Mfn1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion
por: Cao, Yu-Lu, et al.
Publicado: (2017) -
Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development
por: Chen, Hsiuchen, et al.
Publicado: (2003) -
FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion
por: Li, Shuaifeng, et al.
Publicado: (2022) -
Comprehensive analysis of fatty acid metabolism-related gene signatures for predicting prognosis in patients with prostate cancer
por: Wang, Hongbo, et al.
Publicado: (2023) -
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR
por: Luo, Li, et al.
Publicado: (2023)